• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

首例膀胱癌癌肉瘤肿瘤细胞系模型的建立与鉴定报告。

First report on establishment and characterization of a carcinosarcoma tumour cell line model of the bladder.

机构信息

Surgical Department, University Hospital Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.

Institute of Pathology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.

出版信息

Sci Rep. 2021 Mar 16;11(1):6030. doi: 10.1038/s41598-021-85400-5.

DOI:10.1038/s41598-021-85400-5
PMID:33727576
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7971026/
Abstract

Carcinosarcoma of the urinary bladder is a very rare and aggressive subtype of bladder cancer with poor prognosis. Characteristically carcinosarcomas exhibit biphasic nature with both epithelial and mesenchymal differentiation. Limited information is available regarding its clinical features and appropriate treatments due to its rarity. Development of tumour models can further our understanding of bladder carcinosarcoma. We report establishment and characterization of the first-ever bladder carcinosarcoma cell line MaS-3. It is established by the outgrow method from 86 year-old caucasian male who underwent a radical pelvic resection after neoadjuvant radiotherapy. MaS-3 showed carcinosarcoma profile with high conformity with to the original tumour in terms of immunocytochemistry. Proteome analysis also aligned the MaS-3 cell line with the carcinosarcoma specimen rather than corresponding non-malignant tissue. Chemotherapy sensitivity testing revealed a great sensitivity of MaS-3 growth to 5-Fluorouracil, Gemcitabine and Cisplatin, with almost no impact of Irinotecan. Additionally, the suitability of MaS-3 for 3D in vitro experiments was also demonstrated. The newly established cell line MaS-3 shows typical characteristics of the tumour and may thus be a useful in vitro model system for studying the tumour biology and developing future of treatments of this rare but very aggressive entity.

摘要

膀胱癌癌肉瘤是一种非常罕见且侵袭性强的膀胱癌亚型,预后较差。癌肉瘤的特征是具有上皮和间叶分化的双相性。由于其罕见性,关于其临床特征和适当治疗的信息有限。肿瘤模型的发展可以进一步加深我们对膀胱癌肉瘤的理解。我们报告了首例膀胱癌癌肉瘤细胞系 MaS-3 的建立和鉴定。它是通过从一位 86 岁的白人男性的体外培养方法建立的,该男性在新辅助放疗后接受了根治性盆腔切除术。MaS-3 表现出癌肉瘤特征,在免疫细胞化学方面与原始肿瘤高度一致。蛋白质组分析也表明 MaS-3 细胞系与癌肉瘤标本一致,而与相应的非恶性组织不一致。化疗敏感性测试显示 MaS-3 对 5-氟尿嘧啶、吉西他滨和顺铂的生长非常敏感,而伊立替康几乎没有影响。此外,还证明了 MaS-3 适合 3D 体外实验。新建立的 MaS-3 细胞系表现出肿瘤的典型特征,因此可能是研究肿瘤生物学和开发这种罕见但非常侵袭性实体的未来治疗方法的有用体外模型系统。

相似文献

1
First report on establishment and characterization of a carcinosarcoma tumour cell line model of the bladder.首例膀胱癌癌肉瘤肿瘤细胞系模型的建立与鉴定报告。
Sci Rep. 2021 Mar 16;11(1):6030. doi: 10.1038/s41598-021-85400-5.
2
Carcinosarcoma of the urinary bladder--case report and literature review.膀胱癌肉瘤——病例报告及文献综述
Ann Acad Med Singap. 1995 Jul;24(4):640-3.
3
Carcinosarcoma with a large cell neuroendocrine epithelial component: first report of an unusual biphasic tumour of the urinary bladder.伴有大细胞神经内分泌上皮成分的癌肉瘤:膀胱罕见双相性肿瘤的首例报告
J Clin Pathol. 2004 Mar;57(3):318-20. doi: 10.1136/jcp.2003.013474.
4
Bladder carcinosarcomas: three cases with diverse histogenesis.膀胱癌肉瘤:三例组织发生各异的病例。
Histopathology. 1990 Jan;16(1):63-7. doi: 10.1111/j.1365-2559.1990.tb01062.x.
5
Carcinosarcoma of the urinary bladder--an aggressive tumor with diverse histogenesis. A clinicopathologic study of 4 cases and review of the literature.膀胱癌肉瘤——一种具有多种组织发生学的侵袭性肿瘤。4例临床病理研究及文献复习
Arch Pathol Lab Med. 2000 Aug;124(8):1172-8. doi: 10.5858/2000-124-1172-COTUBA.
6
Carcinosarcoma of the urinary bladder: a case report.膀胱癌肉瘤:一例报告
ScientificWorldJournal. 2005 Apr 5;5:274-5. doi: 10.1100/tsw.2005.35.
7
Carcinosarcoma of the urinary bladder. A light, immunohistochemical and electron microscopical case report.膀胱癌肉瘤。一例光镜、免疫组化及电镜病例报告。
Virchows Arch A Pathol Anat Histopathol. 1989;415(1):91-5. doi: 10.1007/BF00718608.
8
[Carcinosarcoma of the urinary bladder].[膀胱癌肉瘤]
Urologe A. 1993 Jan;32(1):59-63.
9
Bladder carcinosarcoma: histologic variation in metastatic lesions.膀胱癌肉瘤:转移病灶的组织学变异
J Urol. 1983 Apr;129(4):829-31. doi: 10.1016/s0022-5347(17)52387-3.
10
[Bladder carcinosarcoma: case report with immunohistologic study].[膀胱癌肉瘤:免疫组织学研究病例报告]
Actas Urol Esp. 1998 Jul-Aug;22(7):557-60.

引用本文的文献

1
Clinical evolution of bladder carcinosarcoma: A case report and literature review.膀胱癌肉瘤的临床演变:一例报告并文献复习。
Medicine (Baltimore). 2024 Aug 9;103(32):e39225. doi: 10.1097/MD.0000000000039225.
2
Clinical efficacy analysis of partial cystectomy and radical cystectomy in the treatment of muscle-invasive sarcomatoid carcinoma of the urinary bladder.膀胱部分切除术与根治性膀胱切除术治疗肌层浸润性膀胱肉瘤样癌的临床疗效分析
Front Oncol. 2024 Feb 2;14:1324487. doi: 10.3389/fonc.2024.1324487. eCollection 2024.
3
Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer.

本文引用的文献

1
A case of combined small cell lung carcinoma with unique morphology: Investigation of tumorigenesis.一例具有独特形态的小细胞肺癌合并病例:肿瘤发生机制的研究。
Pathol Int. 2018 Nov;68(11):618-623. doi: 10.1111/pin.12726. Epub 2018 Oct 12.
2
Proteome Profiling of Primary Pancreatic Ductal Adenocarcinomas Undergoing Additive Chemoradiation Link ALDH1A1 to Early Local Recurrence and Chemoradiation Resistance.接受同步放化疗的原发性胰腺导管腺癌蛋白质组分析将醛脱氢酶1A1与早期局部复发和放化疗耐药联系起来。
Transl Oncol. 2018 Dec;11(6):1307-1322. doi: 10.1016/j.tranon.2018.08.001. Epub 2018 Aug 30.
3
The demographic features, clinical outcomes, prognosis and treatment options for patients with sarcomatoid carcinoma of the urinary bladder: a single centre experience.
患者来源的类器官可确定肉瘤样膀胱尿路上皮癌的个性化治疗方案及可塑性决定因素。
NPJ Precis Oncol. 2023 Nov 2;7(1):112. doi: 10.1038/s41698-023-00466-w.
膀胱肉瘤样癌患者的人口统计学特征、临床结局、预后和治疗选择:单中心经验。
Int Braz J Urol. 2018 Jan-Feb;44(1):45-52. doi: 10.1590/S1677-5538.IBJU.2016.0347.
4
Sarcomatoid Carcinoma of the Urinary Bladder.膀胱肉瘤样癌
Clin Genitourin Cancer. 2016 Oct;14(5):366-372. doi: 10.1016/j.clgc.2016.03.004. Epub 2016 Mar 10.
5
A practical approach to the diagnosis of mixed epithelial and mesenchymal tumours of the uterus.子宫混合性上皮和间叶性肿瘤诊断的实用方法
Mod Pathol. 2016 Jan;29 Suppl 1:S78-91. doi: 10.1038/modpathol.2015.137.
6
Sarcomatoid urothelial carcinoma of the bladder: a contemporary clinicopathologic analysis of 37 cases.膀胱肉瘤样尿路上皮癌:37例病例的当代临床病理分析
Can J Urol. 2015 Jun;22(3):7783-7.
7
Sarcomatoid variant of urothelial carcinoma (carcinosarcoma, spindle cell carcinoma): a review of the literature.尿路上皮癌的肉瘤样变体(癌肉瘤、梭形细胞癌):文献综述
ISRN Urol. 2014 Jan 22;2014:794563. doi: 10.1155/2014/794563. eCollection 2014.
8
Carcinosarcoma of the bladder: a case report and review of the literature.膀胱癌肉瘤:一例报告并文献复习
Case Rep Urol. 2013;2013:716704. doi: 10.1155/2013/716704. Epub 2013 Jul 15.
9
STR DNA typing of human cell lines: detection of intra- and interspecies cross-contamination.人类细胞系的STR DNA分型:种内和种间交叉污染的检测
Methods Mol Biol. 2013;946:27-38. doi: 10.1007/978-1-62703-128-8_3.
10
Five primary human pancreatic adenocarcinoma cell lines established by the outgrowth method.五种通过体外培养方法建立的人胰腺导管腺癌细胞系。
J Surg Res. 2012 Jan;172(1):29-39. doi: 10.1016/j.jss.2011.04.021. Epub 2011 May 7.